Protein Arginine Deiminase
Protein arginine deiminases (PADs) is a unique family of enzymes that catalyzes the hydrolysis of peptidyl-arginine to form peptidyl-citrulline on histones, fibrinogen, and other biologically relevant proteins. In humans, the PAD family is composed of five, calcium dependent isozymes (PADs 1-4 and 6), which share roughly 50% sequence similarity. PADs are found in a myriad of cell and tissue types, including the epidermis and uterus (PAD1), skeletal muscle, brain, inflammatory cells, several cancer cell lines, and secretory glands (PAD2), hair follicles and keratinocytes (PAD3), granulocytes and several types of cancer (PAD4), and oocytes and embryos (PAD6). PAD4, the best characterized isozyme, has also been shown to citrullinate a number of other proteins, including p300, ING4, RPS2, lamin C, and nucleophosmin.
Targets for Protein Arginine Deiminase
Products for Protein Arginine Deiminase
- Cat.No. Product Name Information
-
GC66379
AFM-30a hydrochloride
AFM-30a hydrochloride is a potent protein arginine deiminase 2 (PAD2) inhibitor and has excellent PAD2-selectivity. AFM-30a hydrochloride binds to PAD2 with an EC50 value of 9.5 μM. AFM-30a hydrochloride also inhibits H3 citrullination with an EC50 value of 0.4 μM. AFM-30a hydrochloride can be used for the research of certain cancers and a variety of autoimmune diseases including rheumatoid arthritis (RA), multiple sclerosis, lupus, and ulcerative colitis.
-
GC35480
BB-Cl-Amidine hydrochloride
BB-Cl-Amidine hydrochloride is a peptidylarginine deminase (PAD) inhibitor.
-
GC35706
Cl-amidine
Cl-amidine (N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-l-ornithine amide), is a PAD4 inactivator with enhanced potency.
-
GC18925
Cl-Amidine (hydrochloride)
Cl-amidine is an inhibitor of protein arginine deiminases (PAD; IC50s = 0.8, 6.2, and 5.9 uM for PAD1, PAD3, and PAD4 in vitro, respectively).
-
GC63780
D-Cl-amidine hydrochloride
D-Cl-amidine hydrochloride is a potent and highly selective PAD1 inhibitor. D-Cl-amidine is well-torelated with no significant toxicity.
-
GC19184
GSK484 hydrochloride
GSK484 is a selective PAD4 inhibitor, has been used as an anti-ischemic compound and exerts inhibitory activity against PAD4.
-
GC73447
JBI-589
JBI-589 is a non-covalent PAD4 isoform-selective inhibitor with oral bioavailability.
-
GC67873
PAD-IN-2
-
GC64367
PAD2-IN-1
PAD2-IN-1, a benzimidazole-based derivative, is a potent and selective protein arginine deiminase 2 (PAD2) inhibitor.
-
GC66335
PAD2-IN-1 hydrochloride
PAD2-IN-1 hydrochloride, a benzimidazole-based derivative, is a potent and selective protein arginine deiminase 2 (PAD2) inhibitor. PAD2-IN-1 hydrochloride shows superior selectivity for PAD2 over PAD4 (95-fold) and PAD3 (79-fold).
-
GC73542
PAD4-IN-2 TFA
PAD4-IN-2 (compound 5i) TFA is a PAD4 inhibitor (IC50=1.94 μM).
-
GC32303
Streptonigrin (Bruneomycin)
NSC 45383, NSC 56748, NSC 83950
Streptonigrin (Bruneomycin) (Bruneomycin), a natural product produced by Streptomyces flocculus, possesses both anti-tumor and anti-bacterial activity. -
GC33261
YW3-56